About Jeff Guckert
Guckert is director of finance at Rgenta Therapeutics, which is developing oral small-molecule medicines that target RNA to treat cancer and neurological disorders. He has worked for more than 18 years as a financial executive for early-stage biotech companies, serving as a director of finance and as chief financial officer. He has advised venture-backed companies on financial, strategic and operational matters across small-molecule drug discovery, RNA-targeting therapies, stem cell therapies, medical devices and data-driven therapeutics. He has helped guide companies from inception through later financing rounds, and has helped several companies prepare for and file initial public offerings.
Guckert earned his certified public accountant license while working at PricewaterhouseCoopers in Boston. He also earned a business degree, with an accounting focus, from Notre Dame, in South Bend, Indiana.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Jeff Guckert in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeff Guckert works with at each company, as listed on that company's latest Form D.
